Literature DB >> 9127159

Misoprostol in the management of missed abortion.

Y Herabutya1, P O-Prasertsawat.   

Abstract

OBJECTIVE: To compare the effect of vaginal misoprostol with that of placebo when used prior to dilation and aspiration in women with a missed abortion.
METHOD: Eighty-four pregnant women with a missed abortion were randomized to receive either vaginal misoprostol (200 micrograms) or placebo the day before the planned dilatation and aspiration under inhalation anesthesia. RESULT: Thirty-five women (83.33%) in the misoprostol group and 6 women (17.14%) in the placebo group aborted spontaneously prior to the scheduled dilatation and aspiration, P < 0.0001. The mean insertion to spontaneous expulsion time was 11.63 +/- 6.14 h in the misoprostol group compared to 11.95 +/- 5.43 h in placebo. In the misoprostol group two women required intramuscular pethidine for analgesia. In the placebo group there were two cases of blood loss in excess of 500 ml and one woman with a uterine perforation.
CONCLUSION: Vaginal administration of misoprostol to women with a missed abortion produced spontaneous expulsion of the pregnancy and reduced the need for surgical treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9127159     DOI: 10.1016/s0020-7292(96)02815-9

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

1.  Endometrial thickness after misoprostol use for early pregnancy failure.

Authors:  M D Creinin; B Harwood; R S Guido; M C Fox; J Zhang
Journal:  Int J Gynaecol Obstet       Date:  2004-07       Impact factor: 3.561

Review 2.  Medical treatments for incomplete miscarriage (less than 24 weeks).

Authors:  James P Neilson; Gillian Ml Gyte; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 3.  Medical treatments for incomplete miscarriage.

Authors:  Caron Kim; Sharmani Barnard; James P Neilson; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

4.  Medical treatment for early fetal death (less than 24 weeks).

Authors:  Marike Lemmers; Marianne Ac Verschoor; Bobae Veronica Kim; Martha Hickey; Juan C Vazquez; Ben Willem J Mol; James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

5.  Instability of misoprostol tablets stored outside the blister: a potential serious concern for clinical outcome in medical abortion.

Authors:  Veronique Berard; Christian Fiala; Sharon Cameron; Teresa Bombas; Mirella Parachini; Kristina Gemzell-Danielsson
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

6.  Efficacy of intra-cervical misoprostol in the management of early pregnancy failure.

Authors:  Abdulrahim A Rouzi; Nisma Almansouri; Nora Sahly; Nawal Alsenani; Hussam Abed; Khalid Darhouse; Nabil Bondagji
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379

7.  Complete cervical avulsion with intravaginal misoprostol for second trimester pregnancy termination.

Authors:  G R Sajjan; Neelamma Patil; Manpreet Kaur; Shobha Shirgur; Suvarna Nandi; V Ashwini
Journal:  Case Rep Obstet Gynecol       Date:  2012-08-02

8.  Methods for managing miscarriage: a network meta-analysis.

Authors:  Jay Ghosh; Argyro Papadopoulou; Adam J Devall; Hannah C Jeffery; Leanne E Beeson; Vivian Do; Malcolm J Price; Aurelio Tobias; Özge Tunçalp; Antonella Lavelanet; Ahmet Metin Gülmezoglu; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2021-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.